Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 3
2003 6
2004 5
2005 7
2006 3
2007 10
2008 2
2009 1
2010 5
2011 2
2012 1
2013 5
2014 1
2015 1
2016 3
2017 16
2018 6
2019 8
2020 13
2021 9
2023 15
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
Angiosarcoma after breast-conserving therapy.
Monroe AT, Feigenberg SJ, Mendenhall NP. Monroe AT, et al. Among authors: feigenberg sj. Cancer. 2003 Apr 15;97(8):1832-40. doi: 10.1002/cncr.11277. Cancer. 2003. PMID: 12673708 Free article. Review.
Validation of Patient-Reported Outcomes in Patients With Nonmetastatic Breast Cancer Receiving Comprehensive Nodal Irradiation in the RadComp Trial.
Hahn EA, Pugh SL, Lu HL, Vela AM, Gillespie EF, Nichols EM, Wright JL, MacDonald SM, Cahlon O, Baas C, Braunstein LZ, Fang LC, Freedman GM, Jimenez RB, Kesslering CM, Mishra MV, Mutter RW, Ohri N, Rosen LR, Urbanic JJ, Jagsi R, Mitchell SA, Bekelman JE, Cella D; Study Group Investigators:. Hahn EA, et al. Int J Radiat Oncol Biol Phys. 2024 Sep 1;120(1):149-161. doi: 10.1016/j.ijrobp.2024.03.020. Epub 2024 May 13. Int J Radiat Oncol Biol Phys. 2024. PMID: 38739047 Free PMC article. Clinical Trial.
Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer.
Yegya-Raman N, Berman AT, Ciunci CA, Friedes C, Berlin E, Iocolano M, Wang X, Lai C, Levin WP, Cengel KA, O'Reilly SE, Cohen RB, Aggarwal C, Marmarelis ME, Singh AP, Sun L, Bradley JD, Plastaras JP, Simone CB 2nd, Langer CJ, Feigenberg SJ. Yegya-Raman N, et al. Among authors: feigenberg sj. Int J Radiat Oncol Biol Phys. 2024 May 1;119(1):56-65. doi: 10.1016/j.ijrobp.2023.08.047. Epub 2023 Aug 29. Int J Radiat Oncol Biol Phys. 2024. PMID: 37652303 Clinical Trial.
The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC.
Friedes C, Iocolano M, Lee SH, Duan L, Li B, Doucette A, Cohen RB, Aggarwal C, Sun LL, Levin WP, Cengel KA, Kao G, Teo BK, Langer CJ, Xiao Y, Bradley J, Feigenberg SJ, Yegya-Raman N. Friedes C, et al. Among authors: feigenberg sj. Radiother Oncol. 2024 Jan;190:110030. doi: 10.1016/j.radonc.2023.110030. Epub 2023 Nov 24. Radiother Oncol. 2024. PMID: 38008414
Acute hospitalizations after proton therapy versus intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in the durvalumab era.
Iocolano M, Yegya-Raman N, Friedes C, Wang X, Kegelman T, Lee SH, Duan L, Li B, Levin WP, Cengel KA, Konski A, Langer CJ, Cohen RB, Sun L, Aggarwal C, Doucette A, Xiao Y, Kevin Teo BK, O'Reilly S, Zou W, Bradley JD, Simone CB 2nd, Feigenberg SJ. Iocolano M, et al. Among authors: feigenberg sj. Cancer. 2024 Jun 1;130(11):2031-2041. doi: 10.1002/cncr.35230. Epub 2024 Jan 31. Cancer. 2024. PMID: 38294959
Non-small cell lung cancer.
Ettinger DS, Akerley W, Bepler G, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Feigenberg SJ, Figlin RA, Govindan R, Grannis FW Jr, Jahan T, Jahanzeb M, Kessinger A, Komaki R, Kris MG, Langer CJ, Le QT, Martins R, Otterson GA, Patel JD, Robert F, Sugarbaker DJ, Wood DE. Ettinger DS, et al. Among authors: feigenberg sj. J Natl Compr Canc Netw. 2008 Mar;6(3):228-69. doi: 10.6004/jnccn.2008.0021. J Natl Compr Canc Netw. 2008. PMID: 18377844 No abstract available.
114 results